CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | March/April 2013

Postmarket Surveillance of Vascular Closure Devices

The FDA perspective on VCDs and the importance of continued surveillance.

By Dale R. Tavris, MD, MPH, and Samantha Jacobs, BS

cit | Article | March/April 2013

Access and Closure: Focus on TAVR

By Ted E. Feldman, MD, FESC, FACC, FSCAI

cit | Article | March/April 2017

TAVR: Insights and Perspectives

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC

cit | Article | March/April 2023

Management of THV Degeneration

By Janarthanan Sathananthan, MD, and S. Jay Mathews, MD

Advertisement

Advertisement

cit | Article | March/April 2025

Transcatheter Interventions for Pure AR: From Off-Label Use to Dedicated Devices

Challenges of TAVR in the treatment of pure aortic regurgitation and how dedicated devices can overcome them.

By Sara Waezsada, MD, and Tanja K. Rudolph, MD

cit | Article | March/April 2019

TAVR in Patients With Aortic Stenosis and Low Surgical Risk

Evaluating new clinical trial data to better understand the benefits and limitations of TAVR in patients at low surgical risk.

By Lars Søndergaard, MD, DMSc, and Nicolo Piazza, MD, PhD

cit | Article | March/April 2015

THV Expansion

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | July/August 2012

Transapical TAVR Devices

An era of rapid evolution in transcatheter aortic valve replacement technology.

By Michael A. Borger, MD, PhD; Joerg Seeburger, MD, PhD; Johannes Blumenstein, MD; David M. Holzhey, MD, PhD; and Friedrich W. Mohr, MD, PhD

cit | Article | March/April 2019

Bioprosthetic Valve Fracture During ViV TAVR

A step-by-step practical guide for performing BVF to facilitate ViV TAVR.

By Ahmed Almomani, MD, and Adnan K. Chhatriwalla, MD

cit | Article | May/June 2015

Reaching TAVR's Full Potential by Optimizing Postprocedure Care

Realizing the potential benefits that can be gained when clinical pathways are implemented post-TAVR.

By Christopher U. Meduri, MD, MPH; Vivek Rajagopal, MD; Jim Kauten, MD; Charles Brown IV, BA; David Alexander, PA; Edvin K. Feldt, MD; and Brian J. Potter, MD, MSc

cit | Article | March/April 2022

Conduction Disturbance After TAVR

How to decide for permanent pacing and impact of new pacemakers after TAVR.

By Yasser Sammour, MD, and Samir R. Kapadia, MD

cit | Article | March/April 2017

New Insights From the STS/ACC TVT Registry

What these ongoing data tell us about TAVR and future areas of interest.

By Frederick L. Grover, MD, and David R. Holmes Jr, MD

cit | News | May 27, 2020

TAVR Shown to Be Safe to Treat Bicuspid Valve Disease

May 27, 2020—The American College of Cardiology (ACC) announced the publication of a study demonstrating that transcatheter aortic valve replacement (TAVR) appears to be a safe treatment option with low complication rates for many patients with a bicuspid aortic valve that needs replacing.

Sponsored by Funding for this supplement provided by Medtronic

cit | Article | July/August 2018 Supplement

Aortic Valve-in-Valve Hemodynamics

Considerations for this minimally invasive approach to treating patients with failed bioprostheses.

By Danny Dvir, MD

Funding for this supplement provided by Medtronic

cit | Article | November/December 2016 Supplement

Building an Efficient TAVR Program

By Sandeep M. Patel, MD; J. Brandon Elmore, MD; Edwin G. Avery, MD; Marco A. Costa, MD, PhD; Alan Markowitz, MD; Angela Davis, RN; and Guilherme F. Attizzani, MD; on behalf of The Valve Structural Heart Disease Intervention Center, Harrington Heart and Vascular Institute, Cleveland, OH


1

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button